The Economic Times
12,180.3573.45
Stock Analysis, IPO, Mutual Funds, Bonds & More

New drug can treat type 2 diabetes for children under age 18

Currently only two drugs, metformin and insulin, are approved for the treatment of diabetes in children.

PTI|
Apr 30, 2019, 05.18 PM IST
0Comments
Getty Images
diabetes-children_getty
HOUSTON: Scientists have successfully completed clinical trials of a novel drug to treat Type 2 diabetes in children. Currently only two drugs, metformin and insulin, are approved by the US Food and Drug Administration for the treatment of Type 2 diabetes in children.

By comparison, more than 30 drugs are approved to treat this form of diabetes in adults.

"We've not been able to get drugs approved for children beyond metformin and insulin," said Jane Lynch, from the University of Texas in the US.

"This adult diabetes medication was very effective in our trial of youth with Type 2 diabetes and was well tolerated. We urgently need other options for medical treatment of Type 2 diabetes in our youth under age 18," Lynch said in a statement.

Want To Keep Diabetes Away? Eat Walnuts, Apples, Carrots

of 10
Next
Prev
Play Slideshow

Foods For Diabetics

14 Nov, 2018
While being active, staying hydrated, and checking blood glucose levels can work wonders, it is important to stick to a dietary plan that will ward off diabetes in the long run. A recent study showed that antioxidant-rich walnuts can nearly halve the risk of developing Type-2 diabetes. For patients, the ideal diabetic diet plan would be to have 1200-1600 calories per day. It is recommended that diabetics should eat good carbs, fats, and healthy proteins, but in small portions. Doctors and dieticians share ultimate list of foods you must consume to stay healthy. Also read: The comprehensive diabetes guide
Next

"If approved, this drug would be a fantastic new option to complement oral metformin therapy as an alternative to insulin for our youth and adolescents with Type 2 diabetes," she said.

The study compared outcomes of 66 children who received liraglutide shots plus metformin pills for 26 weeks with the outcomes of 68 other children who received metformin and a placebo.

Researchers measured the children's glycated hemoglobin level -- commonly called "A1C" -- at baseline, at week 26 and at week 52. The change in A1C from baseline to week 26 was the study's primary endpoint.

In the liraglutide group at week 26, mean A1C levels were reduced from baseline by 0.64 per cent, whereas levels increased by 0.42 per cent in the placebo group.

The estimated treatment difference on A1C levels was minus 1.06 per cent, which "showed the superiority of liraglutide to placebo," the researchers wrote.

Cut Sugar, Lose Body Fat & Quit Smoking: Lifestyle Habits To Ditch Diabetes

of 6
Next
Prev
Play Slideshow

Tackling Diabetes

16 Feb, 2019
Diabetes is among the fastest growing health issues today in India.The rising prevalence of diabetes is primarily driven by a combination of various factors such as rapid urbanisation, sedentary lifestyles, unhealthy diets, tobacco use, and even increased life expectancy.Although there are certain factors one can't change such as your genes, age or past behaviours, but there are many actions one can take to reduce the risk of diabetes.Dr Varsha Khatry, Head - Medical and Scientific Affair at Roche Diabetes Care India shares some easy ways to not only reduce the risk of diabetes, but also prevent it.
Next

Also Read

What is Sleeveballoon? New device that can treat Type 2 diabetes, obesity

Dealing with type-2 diabetes? Weight loss during the first five years may help you recover

How tall are you? Experts say shorter women at 33% higher risk of type-2 diabetes

Do you have food neophobia? You may be at higher risk of type 2 diabetes

10 minutes of HIIT workouts can improve heart health of type 2 diabetics

Comments
Add Your Comments
Commenting feature is disabled in your country/region.

Popular Categories


Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service